HDBuzz helps untangle some bold claims about the just-announced results of the PRIDE-HD trial of pridopidine in HD
A new population study reveals that relatively mild forms of the HD mutation are much more common than we thought
HDBuzz summarizes the science from an unusually large and energized @HDSA convention in Baltimore
A confusing story about a huntingtin lowering trial is published in the Telegraph, but cool new stuff is happening!
Stem cells and modeling Huntington's disease in our final Therapeutics Conference report
Researchers design a virus to more effectively deliver gene-silencing drugs throughout the brain.
Major Announcement: First HD patients treated with gene silencing drugs
GeM-HD identifies the first solid leads in the hunt for genetic variations that affect Huntington's disease onset
Variety in the HD gene’s on switch affects when symptoms arise.